Detalhe da pesquisa
1.
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.
Cancer Immunol Immunother
; 70(10): 3015-3030, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120214
2.
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/ß2m overexpression.
Mod Pathol
; 33(3): 468-482, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409873
3.
HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
PLoS Pathog
; 14(4): e1007041, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29709038
4.
Human gut microbiota-reactive DP8α regulatory T cells, signature and related emerging functions.
Front Immunol
; 13: 1026994, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36479125
5.
Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy.
Cancers (Basel)
; 14(17)2022 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077799
6.
Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
Oncoimmunology
; 11(1): 2046931, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35295095
7.
A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening.
Sci Rep
; 11(1): 17234, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446788
8.
High-Density of FcγRIIIA+ (CD16+) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis.
Front Oncol
; 11: 684478, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34211852
9.
Low Levels of Natural Anti-α-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19.
Front Microbiol
; 12: 641460, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643275
10.
MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.
Cancer Immunol Res
; 8(2): 255-267, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857348
11.
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy.
J Immunother Cancer
; 8(2)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188038
12.
CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells.
Oncoimmunology
; 5(12): e1250991, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28123891